Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1974 1
1975 4
1976 6
1977 3
1978 4
1979 1
1980 3
1982 2
1983 1
1984 1
1985 2
1986 3
1988 2
1989 1
1990 1
1994 2
1996 1
1997 1
1998 1
1999 3
2000 1
2002 1
2004 3
2005 4
2007 1
2009 1
2010 3
2011 3
2012 2
2013 1
2014 3
2015 1
2016 3
2017 3
2018 3
2019 4
2020 3
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Understanding and interpreting serum protein electrophoresis.
O'Connell TX, Horita TJ, Kasravi B. O'Connell TX, et al. Am Fam Physician. 2005 Jan 1;71(1):105-12. Am Fam Physician. 2005. PMID: 15663032 Free article. Review.
Electrophoresis separates proteins based on their physical properties, and the subsets of these proteins are used in interpreting the results. Plasma protein levels display reasonably predictable changes in response to acute inflammation, malignancy, trauma, necrosis, infa …
Electrophoresis separates proteins based on their physical properties, and the subsets of these proteins are used in interpreting the result …
Gamma-heavy chain disease.
Kušnierová P, Zeman D, Jelínek T, Hájek R. Kušnierová P, et al. Klin Onkol. 2020 Summer;33(4):282-285. doi: 10.14735/amko2020280. Klin Onkol. 2020. PMID: 32894957 English.
Heavy chain disease.
Witzig TE, Wahner-Roedler DL. Witzig TE, et al. Curr Treat Options Oncol. 2002 Jun;3(3):247-54. doi: 10.1007/s11864-002-0014-3. Curr Treat Options Oncol. 2002. PMID: 12057070 Review.
Heavy Chain Disease of the Small Bowel.
Bianchi G, Sohani AR. Bianchi G, et al. Curr Gastroenterol Rep. 2018 Jan 25;20(1):3. doi: 10.1007/s11894-018-0608-y. Curr Gastroenterol Rep. 2018. PMID: 29372346 Review.
Heavy chain diseases.
Wahner-Roedler DL, Kyle RA. Wahner-Roedler DL, et al. Best Pract Res Clin Haematol. 2005;18(4):729-46. doi: 10.1016/j.beha.2005.01.029. Best Pract Res Clin Haematol. 2005. PMID: 16026747 Review.
Diagnosis of HCD requires documentation of a deleted immunoglobulin heavy chain without a bound light chain in the serum or urine. Prognosis is variable, and no standardized effective treatment programs are available except for alpha-HCD, which in its early stage may respo …
Diagnosis of HCD requires documentation of a deleted immunoglobulin heavy chain without a bound light chain in the serum or urine. Progno …
γ Heavy chain disease.
Nagrale V, Richard L. Nagrale V, et al. Blood. 2019 Mar 21;133(12):1382. doi: 10.1182/blood-2018-11-887133. Blood. 2019. PMID: 30898778 Free article. No abstract available.
Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease.
Martin IG, Aldoori MI. Martin IG, et al. Br J Surg. 1994 Jan;81(1):20-4. doi: 10.1002/bjs.1800810107. Br J Surg. 1994. PMID: 8313111 Review.
Treatment consists of an initial staging laparotomy, with debulking of lymphomatous deposits if appropriate, followed by chemotherapy or radiotherapy. Overall prognosis is poor but the recent use of doxorubicin-based chemotherapy offers some hope for the future....
Treatment consists of an initial staging laparotomy, with debulking of lymphomatous deposits if appropriate, followed by chemotherapy or rad …
Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J, Gallo G. Buxbaum J, et al. Hematol Oncol Clin North Am. 1999 Dec;13(6):1235-48. doi: 10.1016/s0889-8588(05)70123-4. Hematol Oncol Clin North Am. 1999. PMID: 10626147 Free article. Review.
The authors now believe that the nodular glomerulopathic form of NAMIDD is similar in both course and prognosis to AL amyloidosis occurring in the absence of multiple myeloma (primary amyloidosis). ...The distinction is not trivial, for if the authors are correct, t …
The authors now believe that the nodular glomerulopathic form of NAMIDD is similar in both course and prognosis to AL amyloido …
83 results